pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    AVT-001
    Type 1 Diabetes (Juvenile Diabetes) Avotres Inc
  • Phase 2
    AXER-204
    Chronic Spinal Cord Injury ReNetX Bio
  • Phase 2
    AZD-0120
    Refractory Multiple Myeloma Gracell Biotechnologies Inc
  • Phase 2
← prev
page 6 of 50
next →
131
Pain89
Neurology1
AZD-0292
Bronchiectasis
$AZN ASTRAZENECA PLC
  • Phase 2
    AZD-5148
    Clostridioides difficile Infections (Clostridium difficil…$AZN ASTRAZENECA PLC
  • Phase 2
    AZD-5863
    Adenocarcinoma Of The Gastroesophageal Junction$AZN ASTRAZENECA PLC
  • Phase 2
    AZD-7760
    Staphylococcus aureus Infections$AZN ASTRAZENECA PLC
  • Phase 2
    AbGn-268
    Ulcerative Colitis AltruBio Inc
  • Phase 2
    Activated T Lymphocytes
    Hepatocellular Carcinoma Lukas Biomedical Inc
  • Phase 2
    AdAPT-001
    Chondrosarcoma EpicentRx Inc
  • Phase 2
    Adipose Tissue Derived Mesenchymal Stem Cells
    Coronavirus Disease 2019 (COVID-19) CellTex Therapeutics Corp
  • Phase 2
    AlloStemspine
    olastrocel [INN]
    Chronic Low Back Pain (CLBP)$CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
  • Phase 2
    AstroRx
    AstroRx
    Amyotrophic Lateral Sclerosis$NCEL NewcelX Ltd.
  • Phase 2
    AstroStem
    RNL-Astrostem
    Spinal Cord Injury Nature Cell Co., Ltd.
  • Phase 2
    AstroStem-V
    Coronavirus Disease 2019 (COVID-19) Pneumonia Nature Cell Co., Ltd.
  • Phase 2
    Autologous Adipose-derived Stem Cells
    Osteoarthritis CellTex Therapeutics Corp
  • Phase 2
    Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Dopamine Neurons
    Parkinson's Disease Oryon Cell Therapies Inc
  • Phase 2
    BAT-8006
    Epithelial Ovarian Cancer Bio-Thera Solutions Ltd
  • Phase 2
    BAY-3401016
    Alport Syndrome Bayer AG
  • Phase 2
    BB-1701
    Human Epidermal Growth Factor Receptor 2 Positive Breast… Bliss Biopharmaceutical (Hangzhou) Co Ltd
  • Phase 2
    BB-301
    Pabparna
    Oculopharyngeal Muscular Dystrophy$BNTC Benitec Biopharma Inc.
  • Phase 2
    BBP-812
    Canavan Disease Aspa Therapeutics Inc
  • Phase 2
    BBT-207
    Non-Small Cell Lung Cancer Parataxis Korea Inc
  • Phase 2
    BBT-401
    Ulcerative Colitis Parataxis Korea Inc
  • Phase 2
    BBT-877
    Idiopathic Pulmonary Fibrosis Parataxis Korea Inc
  • Phase 2
    BCX-17725
    Netherton Syndrome (Bamboo Hair)$BCRX BIOCRYST PHARMACEUTICALS INC
  • Phase 2
    BDTX-4933
    Metastatic Colorectal Cancer Les Laboratoires Servier SAS
  • Phase 2
    BE-101
    Hemophilia B (Factor IX Deficiency) Be Biopharma Inc
  • Phase 2
    BEAM-201
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$BEAM Beam Therapeutics Inc.
  • Phase 2
    BEAM-301
    Glycogen Storage Disease 1A$BEAM Beam Therapeutics Inc.